{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:36:40Z","timestamp":1787056600323,"version":"build-2736575974"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The angiopoietin-like (ANGPTL) proteins ANGPTL3 and ANGPTL4 are critical lipoprotein lipase (LPL) inhibitors. This review discusses the unique ability of the insulin-responsive protein ANGPTL8 to regulate triglyceride (TG) metabolism by forming ANGPTL3\/8 and ANGPTL4\/8 complexes that control tissue-specific LPL activities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>After feeding, ANGPTL4\/8 acts locally in adipose tissue, has decreased LPL-inhibitory activity compared to ANGPTL4, and binds tissue plasminogen activator (tPA) and plasminogen to generate plasmin, which cleaves ANGPTL4\/8 and other LPL inhibitors. This enables LPL to be fully active postprandially to promote efficient fatty acid (FA) uptake and minimize ectopic fat deposition. In contrast, liver-derived ANGPTL3\/8 acts in an endocrine manner, has markedly increased LPL-inhibitory activity compared to ANGPTL3, and potently inhibits LPL in oxidative tissues to direct TG toward adipose tissue for storage. Circulating ANGPTL3\/8 levels are strongly correlated with serum TG, and the ANGPTL3\/8 LPL-inhibitory epitope is blocked by the TG-lowering protein apolipoprotein A5 (ApoA5).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>ANGPTL8 plays a crucial role in TG metabolism by forming ANGPTL3\/8 and ANGPTL4\/8 complexes that differentially modulate LPL activities in oxidative and adipose tissues respectively. Selective ANGPTL8 inhibition in the context of the ANGPTL3\/8 complex has the potential to be a promising strategy for treating dyslipidemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000910","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T12:01:19Z","timestamp":1699963279000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism"],"prefix":"10.1097","volume":"35","author":[{"given":"Yi","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/eurheartj\/ehab841","article-title":"The dawn of a new era of targeted lipid-lowering therapies","volume":"43","author":"Tokgozoglu","year":"2022","journal-title":"Eur Heart J"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1152\/ajpendo.00195.2021","article-title":"Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8","volume":"321","author":"Sylvers-Davie","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","article-title":"Lipoprotein lipase and its regulators: an unfolding story","volume":"32","author":"Wu","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"2200093","DOI":"10.1002\/adbi.202200093","article-title":"The regulation of triacylglycerol metabolism and lipoprotein lipase activity","volume":"6","author":"Wen","year":"2022","journal-title":"Adv Biol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOL.0000000000000798","article-title":"Angiopoietin-like proteins and postprandial partitioning of fatty acids","volume":"33","author":"DiDonna","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"101140","DOI":"10.1016\/j.plipres.2021.101140","article-title":"An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues","volume":"85","author":"Zhang","year":"2022","journal-title":"Prog Lipid Res"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e2211136119","DOI":"10.1073\/pnas.2211136119","article-title":"A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism","volume":"119","author":"Young","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","article-title":"Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200 000 individuals in the UK Biobank","volume":"54","author":"Jurgens","year":"2022","journal-title":"Nat Genet"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","article-title":"Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels","volume":"424","author":"Zhang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","article-title":"Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism","volume":"303","author":"Ren","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2012.12.025","article-title":"Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family","volume":"430","author":"Fu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1073\/pnas.1315292110","article-title":"Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajhg.2014.01.009","article-title":"Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56 000 whites and blacks","volume":"94","author":"Peloso","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"e1009501","DOI":"10.1371\/journal.pgen.1009501","article-title":"ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease","volume":"17","author":"Helkkula","year":"2021","journal-title":"PLoS Genet"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/clinem\/dgab120","article-title":"Genetic and metabolic determinants of plasma levels of ANGPTL8","volume":"106","author":"Oldoni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41419-022-05029-8","article-title":"ANGPTL8 is a negative regulator in pathological cardiac hypertrophy","volume":"13","author":"Hu","year":"2022","journal-title":"Cell Death Dis"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/ATVBAHA.122.318880","article-title":"Plasma ANGPTL8 levels and risk for secondary cardiovascular events in Japanese patients with stable coronary artery disease receiving statin therapy","volume":"43","author":"Morinaga","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2019.11.011","article-title":"High betatrophin in coronary patients protects from cardiovascular events","volume":"293","author":"Leiherer","year":"2020","journal-title":"Atherosclerosis"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/jcm9020512","article-title":"Evidence for expression and location of ANGPTL8 in human adipose tissue","volume":"9","author":"Catalano-Iniesta","year":"2020","journal-title":"J Clin Med"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"100494","DOI":"10.1016\/j.obmed.2023.100494","article-title":"The impact of gender on the relation of serum angiopoietin-like protein 8 (ANGPTL8) level with metabolic parameters in adults","volume":"40","author":"Hassan","year":"2023","journal-title":"Obesity Med"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"e138777","DOI":"10.1172\/jci.insight.138777","article-title":"ANGPTL8 has both endocrine and autocrine effects on substrate utilization","volume":"5","author":"Oldoni","year":"2020","journal-title":"JCI Insight"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1194\/jlr.RA120000781","article-title":"Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids","volume":"61","author":"Chen","year":"2020","journal-title":"J Lipid Res"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1194\/jlr.M088807","article-title":"On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity","volume":"60","author":"Kovrov","year":"2019","journal-title":"J Lipid Res"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","article-title":"ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase","volume":"6","author":"Chi","year":"2017","journal-title":"Mol Metab"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1194\/jlr.M075689","article-title":"ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance","volume":"58","author":"Haller","year":"2017","journal-title":"J Lipid Res"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"e07898","DOI":"10.1016\/j.heliyon.2021.e07898","article-title":"Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4\/8 complex has reduced EL-inhibitory activity","volume":"7","author":"Chen","year":"2021","journal-title":"Heliyon"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.jlr.2021.100112","article-title":"Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8","volume":"62","author":"Sylvers-Davie","year":"2021","journal-title":"J Lipid Res"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"795370","DOI":"10.3389\/fcvm.2021.795370","article-title":"The potential of ANGPTL8 antagonism to simultaneously reduce triglyceride and increase HDL-cholesterol plasma levels","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1194\/jlr.R082735","article-title":"Cholesteryl ester transfer protein and its inhibitors","volume":"59","author":"Shrestha","year":"2018","journal-title":"J Lipid Res"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"101033","DOI":"10.1016\/j.molmet.2020.101033","article-title":"Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue","volume":"40","author":"Ruppert","year":"2020","journal-title":"Mol Metab"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"e2221888120","DOI":"10.1073\/pnas.2221888120","article-title":"Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase","volume":"120","author":"Kumari","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/eurheartj\/ehad261","article-title":"Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation","volume":"44","author":"Silbernagel","year":"2023","journal-title":"Eur Heart J"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.jlr.2021.100068","article-title":"ApoA5 lowers triglyceride levels via suppression of ANGPTL3\/8-mediated LPL inhibition","volume":"62","author":"Chen","year":"2021","journal-title":"J Lipid Res"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"100198","DOI":"10.1016\/j.jlr.2022.100198","article-title":"An anti-ANGPTL3\/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif","volume":"63","author":"Balasubramaniam","year":"2022","journal-title":"J Lipid Res"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"154395","DOI":"10.1016\/j.metabol.2020.154395","article-title":"ApoCIII: a multifaceted protein in cardiometabolic disease","volume":"113","author":"D\u2019Erasmo","year":"2020","journal-title":"Metabolism"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"100071","DOI":"10.1016\/j.jlr.2021.100071","article-title":"ANGPTL4 sensitizes lipoprotein lipase to PCSK3 cleavage by catalyzing its unfolding","volume":"62","author":"Lund Winther","year":"2021","journal-title":"J Lipid Res"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.jlr.2021.100150","article-title":"Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism","volume":"62","author":"Kersten","year":"2023","journal-title":"J Lipid Res"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1194\/jlr.ILR120000780","article-title":"ANGPTL4 inactivates lipoprotein lipase by catalyzing the irreversible unfolding of LPL's hydrolase domain","volume":"61","author":"Kristensen","year":"2020","journal-title":"J Lipid Res"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"e20958","DOI":"10.7554\/eLife.20958","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"Elife"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"e2026650118","DOI":"10.1073\/pnas.2026650118","article-title":"The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding","volume":"118","author":"Leth-Espensen","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1073\/pnas.1920202117","article-title":"Unfolding of monomeric lipoprotein lipase by ANGPTL4: insight into the regulation of plasma triglyceride metabolism","volume":"117","author":"Kristensen","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"e2214081120","DOI":"10.1073\/pnas.2214081120","article-title":"Angiopoietin-like protein 4\/8 complex-mediated plasmin generation leads to cleavage of the complex and restoration of LPL activity","volume":"120","author":"Zhen","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"e20191865","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J Exp Med"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.jlr.2023.100441","article-title":"Decoding the role of angiopoietin-like protein 4\/8 complex-mediated plasmin generation in the regulation of LPL activity","volume":"64","author":"Chen","year":"2023","journal-title":"J Lipid Res"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.ATV.18.2.258","article-title":"Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men","volume":"18","author":"Byberg","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","article-title":"Role of PAI-1 in hepatic steatosis and dyslipidemia","volume":"11","author":"Levine","year":"2021","journal-title":"Sci Rep"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41591-023-02222-w","article-title":"Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial","volume":"29","author":"Rosenson","year":"2023","journal-title":"Nat Med"},{"key":"R53-20250729","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/en.2016-1894","article-title":"ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice","volume":"158","author":"Gusarova","year":"2017","journal-title":"Endocrinology"},{"key":"R54-20250729","doi-asserted-by":"crossref","first-page":"18502","DOI":"10.1038\/srep18502","article-title":"A lipasin\/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase","volume":"5","author":"Fu","year":"2015","journal-title":"Sci Rep"},{"key":"R55-20250729","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.06.034","article-title":"A first-in-human single ascending dose study of a monoclonal antibody against the ANGPTL3\/8 complex in subjects with mixed hyperlipidemia","volume":"355","author":"Gaudet","year":"2022","journal-title":"Atherosclerosis"},{"key":"R56-20250729","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"key":"R57-20250729","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/ATVBAHA.114.304027","article-title":"Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291)","volume":"34","author":"Sharma","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R58-20250729","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.P800011-JLR200","article-title":"An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients","volume":"49","author":"Pullinger","year":"2008","journal-title":"J Lipid Res"},{"key":"R59-20250729","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1038\/s41598-017-18214-z","article-title":"Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in multiethnic cohorts from Southeast Asia","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"R60-20250729","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1507\/endocrj.EJ22-0024","article-title":"Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitis","volume":"69","author":"Fujita","year":"2022","journal-title":"Endocr J"},{"key":"R61-20250729","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1194\/jlr.M031195","article-title":"Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia","volume":"54","author":"Mendoza-Barber\u00e1","year":"2013","journal-title":"J Lipid Res"},{"key":"R62-20250729","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004563214525767","article-title":"Clinical features and genetic analysis of three patients with severe hypertriglyceridemia","volume":"51","author":"Hooper","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"R63-20250729","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2013.12.009","article-title":"Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant","volume":"233","author":"Albers","year":"2014","journal-title":"Atherosclerosis"},{"key":"R64-20250729","doi-asserted-by":"crossref","first-page":"e172600","DOI":"10.1172\/JCI172600","article-title":"Hypertriglyceridemia in Apoa5 \u2212\/\u2212 mice results from reduced amounts of lipoprotein lipase in the capillary lumen","author":"Yang","year":"2023","journal-title":"J Clin Invest"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:02:09Z","timestamp":1753826529000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000910","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]}}}